These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 11196122

  • 1. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms.
    Oruç S, Sener EC.
    Int Ophthalmol; 1999; 23(2):69-73. PubMed ID: 11196122
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
    Maus TL, Nau C, Brubaker RF.
    Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
    [Abstract] [Full Text] [Related]

  • 5. The one-month effects of topical betaxolol, dorzolamide and apraclonidine on ocular blood flow velocities in patients with newly diagnosed primary open-angle glaucoma.
    Avunduk AM, Sari A, Akyol N, Oztürk O, Kapicioglu Z, Erdöl H, Imamoglu HI.
    Ophthalmologica; 2001 May; 215(5):361-5. PubMed ID: 11528262
    [Abstract] [Full Text] [Related]

  • 6. Resistance to blood flow in the rabbit ophthalmic artery after topical treatment with timolol.
    Liu JH, Li R, Nelson TR, Weinreb RN.
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):103-9. PubMed ID: 17444797
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.
    Stewart WC, Laibovitz R, Horwitz B, Stewart RH, Ritch R, Kottler M.
    Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728
    [Abstract] [Full Text] [Related]

  • 9. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME, Robin AL, Cummings HL, Arkin LM.
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
    Uva MG, Longo A, Reibaldi M, Reibaldi A.
    Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Doppler ultrasonography of the central retinal artery in normals treated with topical timolol.
    Steigerwalt RD, Belcaro G, Cesarone MR, Laurora G, De Sanctis MT, Milazzo M.
    Eye (Lond); 1993 Jun; 7 ( Pt 3)():403-6. PubMed ID: 8224295
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC, Ritch R, Shin DH, Lehmann RP, Shrader CE, van Buskirk EM.
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.